🚀 VC round data is live in beta, check it out!

CureVac Valuation Multiples

Discover revenue and EBITDA valuation multiples for CureVac and similar public comparables like ArriVent BioPharma, TchaikaPharma, Sanofi India, Mega Lifesciences and more.

CureVac Overview


Founded

N/A

HQ

Employees

1.1K

Website

N/A

Financials (FY)

Revenue:
Net Income:

EV

$599M

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

CureVac Stock Performance

CureVac has current market cap of $1B, and enterprise value of $599M.

EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$599M$1BXXXXXXXXX

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

CureVac Valuation Multiples

CureVac Financial Valuation Multiples

As of March 7, 2026, CureVac has market cap of $1B and EV of $599M.

Equity research analysts estimate CureVac's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$1BXXX$1BXXXXXXXXX
EV (current)$599MXXX$599MXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified CureVac Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

CureVac Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
ArriVent BioPharmaXXXXXXXXXXXXXXXXXX
TchaikaPharmaXXXXXXXXXXXXXXXXXX
Sanofi IndiaXXXXXXXXXXXXXXXXXX
Mega LifesciencesXXXXXXXXXXXXXXXXXX
Kaken PharmaceuticalXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

CureVac M&A Activity

CureVac acquired XXX companies to date.

Last acquisition by CureVac was on XXXXXXXX, XXXXX. CureVac acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by CureVac

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

CureVac Investment Activity

CureVac invested in XXX companies to date.

CureVac made its latest investment on XXXXXXXX, XXXXX. CureVac invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by CureVac

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About CureVac

How many employees does CureVac have?As of today, CureVac has over 1K employees.
Is CureVac publicly listed?Yes, CureVac is a public company listed on Nasdaq.
What is the stock symbol of CureVac?CureVac trades under CVAC ticker.
When did CureVac go public?CureVac went public in 2020.
Who are competitors of CureVac?CureVac main competitors are ArriVent BioPharma, TchaikaPharma, Sanofi India, Mega Lifesciences.
What is the current market cap of CureVac?CureVac's current market cap is $1B.
Is CureVac profitable?No, CureVac is not profitable.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial